Tonix Pharmaceuticals Holding Corp. reports results for the quarter ended June 30 - Earnings Summary

Tonix Pharmaceuticals Holding

10/08/2026 14:31

Tonix Pharmaceuticals Holding Corp. TNXP.OQ reported a quarterly adjusted loss of $2.44​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-3.86.  The mean expectation of five analysts for the quarter was for a loss of $2.70 per share. Wall Street expected results to range from $-2.89 to $-2.44 per share.
Revenue rose 577.9% to $13.54 million from a year ago; analysts expected $7.72 million. 
Tonix Pharmaceuticals Holding Corp.'s reported EPS for the quarter was a loss of $2.44​.
The company reported a quarterly loss of $40.55 million.
Tonix Pharmaceuticals Holding Corp. shares had fallen by 5.7% this quarter and lost 23.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 6.7% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy" 
Wall Street's median 12-month price target for Tonix Pharmaceuticals Holding Corp. is $34.00, about 64.6% above its last closing price of $12.03
This summary was machine generated from LSEG data August 10 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-2.70
-2.44
Beat
Mar. 31 2026 
-2.43
-2.93
Missed
Dec. 31 2025 
-3.19
-3.98
Missed
Sep. 30 2025 
-3.58
-3.59
Missed